ZORVOLEX

This brand name is authorized in Ecuador, United States

Active ingredients

The drug ZORVOLEX contains one active pharmaceutical ingredient (API):

1 Diclofenac UNII 144O8QL0L1 - DICLOFENAC

Diclofenac is a non-steroidal anti-inflammatory drug. The mechanism of action of diclofenac in AK may be related to the inhibition of the cycloxygenase pathway leading to reduced prostaglandin E2 (PGE2) synthesis. In addition, immunohistochemistry (IHC) from skin biopsies ac revealed that the clinical effects of diclofenac in AK are primarily due to anti-inflammatory, anti-angiogenic and possibly anti-proliferative effects and apoptosis-inducing mechanisms. Read about Diclofenac

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
ZORVOLEX Capsule	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
M01AB05	Diclofenac	M Musculo-skeletal system → M01 Antiinflammatory and antirheumatic products → M01A Antiinflammatory and antirheumatic products, non-steroids → M01AB Acetic acid derivatives and related substances
Discover more medicines within M01AB05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 4507-MEE-1218
Country: US	FDA, National Drug Code	Identifier(s): 42211-203, 42211-204, 69344-203, 69344-204